Kross Limited Reports No Deviation in IPO Fund Utilization for Q4FY26
Kross Limited filed a regulatory statement on May 12, 2026 confirming no deviation in IPO fund utilization for the quarter ended March 31, 2026. The company raised INR 2500 million via IPO on September 12, 2024, with net proceeds of INR 2369.19 million deployed across capital expenditure, debt repayment, working capital, and general corporate purposes as per the prospectus. Actual issue expenses of INR 130.81 million were lower than the estimated INR 138.08 million, with the INR 7.27 million balance proposed for general corporate purposes.

*this image is generated using AI for illustrative purposes only.
Kross Limited has confirmed that there was no deviation or variation in the utilization of proceeds from its Initial Public Offering (IPO) for the quarter ended March 31, 2026. In a regulatory filing submitted on May 12, 2026, pursuant to Regulation 32 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company stated that the funds were deployed strictly in accordance with the objects mentioned in the prospectus. The Audit Committee reviewed the utilization statement, and no comments were raised by either the auditors or the committee regarding the fund deployment.
IPO Fund Raising Details
Kross Limited raised funds through an IPO on September 12, 2024. The total amount raised was INR 2500 million, comprising a fresh issue and an offer for sale. The net proceeds from the issue amounted to INR 2369.19 million. India Ratings and Research Private Limited serves as the monitoring agency for the fund utilization. The company reported that all allocated funds have been utilized for their designated purposes during the reported quarter.
Breakdown of Fund Allocation
The following table details the utilization of IPO proceeds against the original and modified objects for the quarter ended March 31, 2026:
| Original Object: | Original Allocation (INR million) | Modified Allocation (INR million) | Funds Utilised (INR million) |
|---|---|---|---|
| Funding of capital expenditure requirements for machinery and equipment | 700.00 | Not Applicable | 700.00 |
| Repayment or prepayment of borrowings from banks and financial institutions | 900.00 | Not Applicable | 900.00 |
| Funding working capital requirements of the Company | 300.00 | Not Applicable | 300.00 |
| General corporate purposes | 461.92 | 469.19 | 469.19 |
| Total (A) | 2361.92 | 2369.19 | 2369.19 |
| Offer Expenses (B) | 138.08 | 130.81 | 130.81 |
| Total (A+B) | 2500.00 | 2500.00 | 2500.00 |
The actual issue expense was INR 130.81 million against the estimated INR 138.08 million. The balance of INR 7.27 million, resulting from lower-than-estimated expenses, has been proposed to be utilized for General Corporate Purposes. Consequently, the allocation for general corporate purposes was adjusted from INR 461.92 million to INR 469.19 million. The company confirmed that there were no deviations in the usage of funds for all specified objects.
Regulatory Compliance
The statement was signed by Debolina Karmakar, Company Secretary and Compliance Officer, on May 12, 2026, and submitted to both BSE Limited and the National Stock Exchange of India Limited. The filing is also available on the company's official website. The company's registered and corporate office is located at M-4, VI Phase, Gamharia, Adityapur Industrial Area, Jamshedpur - 832108, India.
Historical Stock Returns for Kross
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.91% | -0.28% | +1.40% | +12.43% | +7.46% | -27.22% |
How has the capital expenditure on machinery and equipment funded through the IPO proceeds impacted Kross Limited's production capacity and revenue growth since September 2024?
With all IPO proceeds now fully utilized, what are Kross Limited's plans for future capital raising to fund its next phase of expansion or growth initiatives?
How has the repayment of INR 900 million in borrowings affected Kross Limited's debt-to-equity ratio and overall financial health, and what is the company's current leverage position?


































